|Bid||72.38 x 38700|
|Ask||72.40 x 105300|
|Day's range||72.12 - 72.72|
|52-week range||53.50 - 81.10|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||16.52|
|Earnings date||29 Oct 2020|
|Forward dividend & yield||1.20 (1.65%)|
|Ex-dividend date||28 Aug 2020|
|1y target est||80.61|
Fresenius Medical Care, the world’s leading provider of dialysis products and services, today announced the launch of the organization’s first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific. On 17 September each year, the World Health Organization (WHO), international partners and all countries commemorate World Patient Safety Day: a day that aims to increase global awareness of the need to protect patients in healthcare settings. Fresenius Medical Care Asia Pacific has chosen this important day to highlight the crucial role that ultrapure dialysis fluid (UPDF) plays in reducing morbidity and mortality in hemodialysis (HD) patients,1 and to launch a multi-year initiative providing ongoing healthcare professional education to increase the uptake of high-quality dialysis fluid.
Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.
Fresenius Medical's (FMS) second-quarter earnings benefit from strong segmental performance.